Sign Up to like & get
recommendations!
1
Published in 2017 at "Blood"
DOI: 10.1182/blood-2016-12-754523
Abstract: In this issue of Blood, Gavriatopoulou and colleagues report the mature results of the European Myeloma Network (EMN)–conducted phase 2 trial evaluating the activity of bortezomib, dexamethasone, and rituximab (BDR) in treatment-naive patients with Waldenstrom…
read more here.
Keywords:
bidder bdr;
bdr revisits;
another bidder;
bdr ... See more keywords